GO
Loading...

Enter multiple symbols separated by commas

Health Care Equipment

More

  • NEW YORK— Medical device maker Medtronic said Friday it expanded its stock repurchase authorization, raised its quarterly dividend, and completed two acquisitions for about $200 million total. Medtronic PLC raised its quarterly dividend to 38 cents from 30.5 cents. Medtronic paid $93 million to buy CardioInsight Technologies, a Cleveland company that...

  • June 12- The U.S. Food and Drug Administration said it approved a brain implant from St. Jude Medical Inc that helps reduce symptoms of Parkinson's disease and essential tremor, a neurological disorder that causes rhythmic shaking. The device can be used when medication alone may not provide adequate relief from symptoms such as walking difficulties, balance...

  • Bad news is good for these stocks Wednesday, 10 Jun 2015 | 7:07 PM ET

    Bad news has been a boon for Malaysia's rubber glove makers, with the ringgit's drop and South Korea's MERS outbreak likely to provide a twin boost.

  • Insulet gets FDA warning letter over some insulin pumps Wednesday, 10 Jun 2015 | 6:05 PM ET

    June 10- Insulet Corp said on Wednesday it received a warning letter from the U.S. Food and Drug Administration over some of the company's insulin pumps. The company said the letter, which it received on Monday, followed an inspection by the FDA of its facility in Billerica, Massachusetts in March. The letter relates to the release of certain lots of the company's...

  • June 2- Medical device maker Medtronic Plc reported better-than-expected adjusted quarterly profit on higher sales across its business lines in its first quarter, including revenue from the acquisition of surgical products provider Covidien Plc. Wall Street shrugged off the currency hit, with Medtronic's shares edging slightly higher to $76.72 in...

  • June 2- Medical device maker Medtronic Plc reported a better-than-expected adjusted quarterly profit, helped by higher sales of its heart devices. The results are the first to include revenue generated by Covidien, which Medtronic acquired in January for $49.9 billion. Medtronic said on Tuesday revenue from its minimally invasive therapies group, which it...

  • June 2- Medical device maker Medtronic Inc reported a better-than-expected adjusted quarterly net income, helped by sales of its heart devices. The company's adjusted net profit rose to $1.68 billion, or $1.16 per share. The quarterly results are the first to include revenue generated by Covidien Plc, which Medtronic acquired in January for $49.9 billion.

  • Biotech isn't only health-care bet beating market Monday, 1 Jun 2015 | 10:09 AM ET
    An employee works on a stent graft component in a sterile environment at the Medtronic assembly plant in Tijuana, Mexico.

    The health-care sector is hot, and investors don't have to bet on the riskiest biotech stocks to profit.

  • BOSTON, May 22- Barington Capital Group won its proxy contest by scoring two board seats at Eastern Co this week as shareholders widely backed the activist hedge fund's call to add new blood at the industrial hardware maker. Shareholders elected Barington Chief Executive Officer James Mitarotonda and Michael McManus, CEO of medical device manufacturer...

  • May 19- Heart device maker Edward Lifesciences Corp said it had stopped enrolling patients in a study testing its experimental heart valve due to the formation of blood clots. The experimental heart valve, Fortis, has been implanted in more than 20 patients, Edward Lifesciences said. The medical device maker's shares fell as much as 4.7 percent to $125.44...

  • April 28- Medical device maker Boston Scientific Corp cut its full-year revenue and profit forecasts as it continues to bear the brunt of charges from a number of lawsuits. Boston Scientific said in February it would pay Johnson& Johnson $600 million to settle a long-running lawsuit over Boston Scientific's acquisition of rival Guidant in 2005..

  • Boston Scientific posts loss on litigation costs Tuesday, 28 Apr 2015 | 7:22 AM ET

    April 28- Medical device maker Boston Scientific Corp reported a quarterly net loss due to one-time charges, including litigation costs of $193 million. The company reported a net loss of $1 million for the first quarter ended March 31, compared with a profit of $133 million a year earlier. Excluding charges, the company earned 21 cents per share.

  • April 27- Medtronic Plc has agreed to stop manufacturing and distributing its SynchroMed implantable drug pump, U.S. regulators said on Monday, a step toward resolving allegations that the company violated quality standards with the device which delivers pain medication to cancer patients and others. Medtronic failed to correct problems that could lead to...

  • April 27- Medtronic Plc has agreed to resolve U.S. regulators' allegations it violated quality standards for making its SynchroMed implantable infusion pump, which delivers medications to cancer patients and others with chronic pain. The agreement includes Medtronic Chief Executive Omar Ishrak and Senior Vice President Thomas Tefft.

  • April 27- Medical device maker Medtronic Plc said it reached a settlement agreement with the U.S. Food and Drug Administration over one of the company's drug delivery systems. The consent decree places some restrictions on the company and outlines the steps it must take to address the FDA's expectations, the company said on Monday. The agreement does not...

  • One start-up's quest to prevent breast cancer Tuesday, 21 Apr 2015 | 10:31 AM ET
    Mary-Claire King, the University of Washington geneticist whose work led to the discovery of the BRCA1 gene

    Color Genomics plans to charge only $249 for an analysis of cancer-risk genes. New York Times reports.

  • Hand us your data, we'll cut your rates: Hancock Sunday, 19 Apr 2015 | 11:00 AM ET
    The Fitbit Flex

    John Hancock aims to use wearables to track policyholders' activity, using the information to provide differential pricing on insurance policies.

  • UPDATE 1-FDA approves AcuFocus' corneal implant Friday, 17 Apr 2015 | 6:37 PM ET

    April 17- The U.S. Food and Drug Administration approved AcuFocus Inc's corneal implant to improve vision in patients with presbyopia, an age-related eye disorder. The device, KAMRA inlay, is the first implantable device to correct vision in patients who have not had cataract surgery, the FDA said in a statement on Friday. The FDA, however, warned that the device...

  • FDA approves AcuFocus' corneal implant Friday, 17 Apr 2015 | 5:49 PM ET

    April 17- The U.S. Food and Drug Administration approved AcuFocus Inc's corneal implant to improve vision in patients with presbyopia, an age-related eye disorder. The device, KAMRA inlay, is the first implantable device to correct vision in patients who have not had cataract surgery, the FDA said in a statement on Friday. Presbyopia is a condition associated...

  • NEW YORK, April 12- Medical researchers call it the "Angelina Effect," the surge in demand for genetic testing attributable to movie star Angelina Jolie's public crusade for more aggressive detection of hereditary breast and ovarian cancer. But there's a catch: Major insurance companies including Aetna, Anthem and Cigna are declining to pay for the latest...